Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis

The Journal of Infectious Diseases
Duncan A ClarkPaul D Griffiths

Abstract

We identified a stem cell donor with chromosomally integrated human herpesvirus (HHV)-6 and monitored the recipient for HHV-6 after transplantation. The appearance and subsequent increase in HHV-6 load paralleled engraftment and an increase in white blood cell count. Fluorescent in situ hybridization analysis showed integrated HHV-6 on chromosome band 17p13.3 in the donor and in the recipient after transplantation but not in the recipient before transplantation. The increase in viral load due to the genetic transmission of integrated HHV-6 could have been misinterpreted as substantial active infection and, thus, led to the administration of toxic antiviral therapy. We suggest that the confounding influence of integration be considered in laboratory investigations associating HHV-6 with disease.

Citations

May 10, 2012·Archives of Virology·Abdel Raouf Abou El AzmMohamed Labib Salem
Apr 24, 2010·International Journal of Hematology·Per Ljungman
Jul 1, 2008·Bone Marrow Transplantation·P LjungmanUNKNOWN European Conference on Infections in Leukemia
Aug 21, 2007·Bone Marrow Transplantation·P HubacekP Sedlacek
Sep 9, 2006·The Journal of Infectious Diseases·David BoutolleauAgnès Gautheret-Dejean
Sep 9, 2006·The Journal of Infectious Diseases·Mario LuppiGiuseppe Torelli
Nov 17, 2006·The Journal of Infectious Diseases·Abla AchourHenri Agut
Jan 22, 2010·The Journal of Infectious Diseases·Caroline Breese HallGeraldine K Lofthus
May 14, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sang-Oh LeeRaymund R Razonable
Jun 14, 2008·Journal of Clinical Microbiology·Louis FlamandDharam Ablashi
Jul 29, 2011·Journal of Virology·Huiquan LiuDaohong Jiang
Sep 17, 2010·Journal of Virology·Guillaume Morissette, Louis Flamand
Sep 14, 2012·Therapeutic Advances in Neurological Disorders·Uta Meyding-Lamadé, Cornelia Strank
Jul 30, 2011·Future Virology·Christopher M TraylenShaw M Akula
Apr 15, 2011·Uirusu·Huamin TangYasuko Mori
Jan 2, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Céline Bressollette-BodinBerthe-Marie Imbert-Marcille
Jan 24, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D A Clark
Feb 4, 2012·Journal of Virological Methods·Teemu KarlssonIrmeli Lautenschlager
Jul 26, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Henri Agut
Apr 5, 2011·Microbes and Infection·Jesse H Arbuckle, Peter G Medveczky
Jun 10, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·John R CrawfordTobey J Macdonald
Mar 27, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Hélène JeulinVéronique Venard
Mar 7, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Abla AchourAgnès Gautheret-Dejean
Feb 27, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Andru Tomoiu, Louis Flamand
Feb 6, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Danielle M Zerr
Jun 13, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L PotenzaM Luppi
Apr 3, 2007·Letters in Applied Microbiology·F Cobo, A Concha
Jan 6, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A HumarUNKNOWN VICTOR study group
Sep 25, 2008·Journal of Medical Virology·Elisabeth P NachevaDuncan A Clark
Nov 5, 2011·Reviews in Medical Virology·Philip E PellettRaymund R Razonable
Oct 21, 2011·Journal of Medical Virology·Michelle DupuisNorma P Tavakoli
Jan 17, 2012·Journal of Medical Virology·Delphine CaïolaAgnès Gautheret-Dejean
Mar 8, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J LeUNKNOWN AST Infectious Diseases Community of Practice
Jul 25, 2012·Journal of Medical Virology·Masaru IhiraTetsushi Yoshikawa
Sep 3, 2011·Transplant Infectious Disease : an Official Journal of the Transplantation Society·F ForestM Peoc'h

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.